Tag Archives: Novavax

The Wall Street Journal reports: An experimental Covid-19 vaccine from Novavax was 90.4% effective at preventing symptomatic disease in adults in a large clinical trial, the company said, results that move the shot a step closer to global use. The 29,960-person study conducted in the U.S. and Mexico also found that the vaccine was similarly effective against newer coronavirus strains, …

USA Today reports: Another COVID-19 candidate vaccine appears to be safe and roughly 90% effective against the virus that causes the disease. It also protects against at least a few of the variants that have arisen in recent months. On Thursday, Novavax, a Gaithersburg, Maryland-based biotechnology firm, released interim results from two clinical trials of its candidate vaccine, one in …

Reuters reports: Novavax has begun a large late-stage study of its experimental Covid-19 vaccine in the United States, the drug developer said on Monday, after delaying the trial twice due to issues in scaling up the manufacturing process. It will enroll up to 30,000 volunteers across about 115 sites in the United States and Mexico, with two-thirds of them receiving …

The Washington Post reports: President Trump will seek to put a spotlight on efforts to rapidly develop a coronavirus vaccine with a visit Monday to a North Carolina facility working on components of one of the candidates. Trump is scheduled to take a tour and receive a briefing during his afternoon stop at Bioprocess Innovation Center at Fujifilm Diosynth Biotechnologies …

Reuters reports: The U.S. government has awarded Novavax $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021. Shares of Novavax surged more than 35% in the premarket on the news. The award is the biggest yet from “Operation Warp Speed,” the …

Yahoo Finance reports: Novavax is the latest biotech company to announce that it is entering its vaccine in clinical trials. It’s recombinant technology, already tested in a late-stage flu vaccine trial, focuses on using DNA from the virus to create a vaccine. The Phase 1 clinical trial in Australia is the first in the Southern Hemisphere, and is focusing on …